Northwire Canada EditionFriday, July 10, 2026
Northwire
FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9% FCI 0.400 −9.1% GR 0.075 +0.0% AII 22.38 +7.6% TUNG 1.72 +1.8% LGO 1.01 −2.4% EMM 0.080 +0.0% OGN 3.45 +2.1% MSA 6.30 −2.0% SGZ 0.045 +0.0% S 0.135 +12.5% GRSL 0.310 −3.1% DEX 0.390 +1.3% WMS 0.040 +0.0% EMPR 0.840 +2.4% SAGA 0.480 +0.0% ABX 51.73 −0.9%
Financings Admin

DR. PHONE FIX ANNOUNCES FIRST TRANCHE CLOSING OF NON-BROKERED CONVERTIBLE DEBENTURE UNIT FINANCING

DPF · Price

Executive Summary

  • Dr. Phone Fix Canada Corporation has closed the first tranche of its non-brokered convertible debenture unit financing, raising aggregate gross proceeds of $882,000.
  • The company issued 882 units, each comprising a $1,000 unsecured convertible debenture and 3,125 common share purchase warrants.
  • A finder's fee was paid consisting of $59,990 in cash and 374,937 common share purchase warrants exercisable at $0.22 per share.

Key Details

  • Transaction Structure: Non-brokered private placement of convertible debenture units.
  • Units Issued: 882 units at a price of $1,000 per unit.
  • Gross Proceeds: $882,000.
  • Unit Composition: Each unit includes one $1,000 principal amount unsecured convertible debenture and 3,125 common share purchase warrants.
  • Finder's Compensation: Aggregate cash fee of $59,990 plus 374,937 common share purchase warrants (Finder's Warrants) issued to qualified arm's length parties.
  • Finder's Warrant Terms: Exercisable to acquire one common share at an exercise price of $0.22, exercisable for 24 months from the date of issuance.
  • Hold Period: All securities issued pursuant to the offering, including shares issuable upon conversion or warrant exercise, are subject to a statutory hold period of four months and one day from closing.
  • Regulatory Status: Offering remains subject to final acceptance by the TSX Venture Exchange (TSXV).
  • Use of Proceeds: Not explicitly disclosed in this release.
Read the original news release →

More from Dr. Phone Fix Canada Corporation